FTHFX
Price
$58.59
Change
-$0.30 (-0.51%)
Updated
Jul 17 closing price
Net Assets
12.15B
IRSIX
Price
$13.64
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Net Assets
399.9M
Interact to see
Advertisement

FTHFX vs IRSIX

FTHFX vs IRSIX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. IRSIX commentary
Jul 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and IRSIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. IRSIX (400M). IRSIX pays higher dividends than FTHFX: IRSIX (0.95) vs FTHFX (0.57). FTHFX was incepted earlier than IRSIX: FTHFX (15 years) vs IRSIX (18 years). IRSIX (1.11) is less costly to investors than FTHFX (0.64). FTHFX is a more actively managed with annual turnover of: 28.00 vs. IRSIX (11.00). IRSIX has a lower initial minimum investment than FTHFX: IRSIX (0) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : 26.24 vs. IRSIX (16.75). FTHFX return over 5 years is better than : 68.74 vs. IRSIX (-12.21).
FTHFXIRSIXFTHFX / IRSIX
Total Expense Ratio0.640.9369%
Annual Report Gross Expense Ratio0.641.1158%
Fund Existence15 years18 years-
Gain YTD15.7685.652279%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B400M3,025%
Annual Yield % from dividends0.570.9560%
Returns for 1 year26.2416.75157%
Returns for 3 years52.5710.19516%
Returns for 5 years68.74-12.21-563%
Returns for 10 years233.9915.741,487%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZKIN1.390.04
+2.96%
ZK International Group Co Ltd
CHKP137.100.59
+0.43%
Check Point Software Technologies Ltd
OSW26.41-0.22
-0.83%
OneSpaWorld Holdings Limited
MSS0.56-0.01
-0.98%
Maison Solutions Inc.
CBIO14.75-0.36
-2.38%
Crescent Biopharma Inc